Sergio Slawka

Sergio Slawka has an extensive work experience in the field of medical and clinical development. Sergio has held various senior and executive-level positions in multiple pharmaceutical companies.

Starting from their most recent position, Slawka is currently serving as the Executive Medical Director of Global Clinical Development at Travere Therapeutics. In this role, they are responsible for providing clinical and scientific oversight and leadership for the company's development programs and clinical research projects. Sergio collaborates with all functions, including clinical operations, to develop and deliver an efficient and high-quality clinical development strategy for rare metabolic diseases and other therapeutic areas.

Prior to this, Slawka worked as the Senior Medical Director of Global Clinical Development at uniQure. In this role, they provided medical input for gene therapy programs in rare diseases, including inherited metabolic, hemophilia, and neurocognitive disorders. Sergio also collaborated with other departments to provide medical perspective on orphan indications and unmet needs for gene therapy-based product candidates.

Before joining Travere Therapeutics and uniQure, Slawka held several other senior positions in companies such as RENEURON GROUP PLC, Karyopharm, Aegerion Pharmaceuticals, Vertex Pharmaceuticals, LFB USA/rEVO Biologics, Shire Pharmaceuticals, Biogen, and Genzyme.

Throughout their career, Slawka has demonstrated expertise in clinical operations, medical affairs, and global clinical development. Sergio has contributed to the strategic planning and execution of clinical trials, provided medical leadership and monitoring, and developed medical strategies for product launches. Sergio has also collaborated with key opinion leaders, facilitated regulatory approvals, and ensured scientific communication and compliance with legal requirements.

Overall, Slawka's work experience highlights their strong background in clinical and medical development, with a focus on rare diseases and gene therapy programs.

Sergio Slawka has pursued education in various fields including Medicine, Oncology, Business, Pharmaceutical Medicine, and Public Health. However, no specific degree or field of study is provided.